S
Scarlet
EU & UK certification for AI medical devices
About Scarlet
Scarlet is a startup that operates in the healthcare technology sector, specifically focusing on the certification of Software Medical Devices. The company has identified a gap in the market where the current regulatory environment is not adequately equipped to handle the rapidly evolving field of health and medicine software. To address this, Scarlet has developed a framework that enables both manufacturers and regulators to build and monitor software products in a scalable and continuous manner.
The company's primary clients are manufacturers of Software Medical Devices and regulatory bodies. By providing a platform for the efficient certification of these devices, Scarlet helps to expedite the process of getting life-saving technology to the people who need it. This not only ensures better and safer products reach more patients, but also contributes to the broader goal of making healthcare more accessible and affordable for everyone, everywhere.
Scarlet's business model is service-based. They make money by offering their certification framework to manufacturers. Interested parties can register on their website to schedule a call or a demo, and to receive news and updates from the company.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- London, United Kingdom
- Employees
- 90
- Open positions
- None listed
- Dealroom signal
- 87.6/100
- Industry
- Health, Enterprise Software
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Core AI, Tech for Hospitals and Clinics, Hard Tech, AI Applications, uk is8 digital and technologies, uk is8 life sciences
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2024 | $18M | $70M | Atomico | — |
| SEED✓Equity / VC | Aug 2022 | $7.9M | $32M | Creandum | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Scarlet is 8.2K monthly website visits, up 39% over the last three months. Scarlet's team grew 38.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Kindred Capital
Entrepreneurs First
Creandum
Series A1 investor entered at this stage
Other known investors1 additional known investor
Gemma Bloemen
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Scarlet on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Scarlet’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.